Tofajak 5 mg Tofacitinib Tablets | Cipla | For Rheumatoid Arthritis & Psoriatic Arthritis Treatment

$60.00

Product Description

Tofajak 5 mg contains Tofacitinib, a Janus kinase (JAK) inhibitor used to treat Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative Colitis. Manufactured by Cipla, a trusted name in pharmaceuticals, this medication offers an effective oral treatment alternative for patients who have not responded well to conventional DMARDs (Disease-Modifying Anti-Rheumatic Drugs).

Tofajak helps reduce joint pain, stiffness, inflammation, and damage, improving quality of life and mobility in chronic autoimmune conditions.

Dosage & Usage Instructions

  • Typical Adult Dose: 5 mg twice daily (as prescribed by your physician).

  • Take with or without food.

  • Do not crush or split the tablet.

  • Always follow the prescribed dosage schedule.

  • Regular blood tests may be required to monitor liver function, cholesterol, and white blood cell count.

 

Warnings:

  • Not suitable for patients with serious infections or liver disease.

  • Avoid use during pregnancy or breastfeeding unless advised by a doctor.

  • Avoid live vaccines while on this medication.

Order Now

Category:

Product Description

Tofajak 5 mg contains Tofacitinib, a Janus kinase (JAK) inhibitor used to treat Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative Colitis. Manufactured by Cipla, a trusted name in pharmaceuticals, this medication offers an effective oral treatment alternative for patients who have not responded well to conventional DMARDs (Disease-Modifying Anti-Rheumatic Drugs).

Tofajak helps reduce joint pain, stiffness, inflammation, and damage, improving quality of life and mobility in chronic autoimmune conditions.

Dosage & Usage Instructions

  • Typical Adult Dose: 5 mg twice daily (as prescribed by your physician).

  • Take with or without food.

  • Do not crush or split the tablet.

  • Always follow the prescribed dosage schedule.

  • Regular blood tests may be required to monitor liver function, cholesterol, and white blood cell count.

 

Warnings:

  • Not suitable for patients with serious infections or liver disease.

  • Avoid use during pregnancy or breastfeeding unless advised by a doctor.

  • Avoid live vaccines while on this medication.

0 reviews for Tofajak 5 mg Tofacitinib Tablets | Cipla | For Rheumatoid Arthritis & Psoriatic Arthritis Treatment

Be the first to review “Tofajak 5 mg Tofacitinib Tablets | Cipla | For Rheumatoid Arthritis & Psoriatic Arthritis Treatment”

Your email address will not be published. Required fields are marked *

Welcome to Medizamed                                                                             Affordable & Genuine Medicines Delivered to Your Doorstep – Worldwide Shipping!                                                                                            Bulk Orders Open for Hospitals, Wholesalers & Distributors                                                                                                            💊 5+ Years Export Experience | 70,000+ Satisfied Customers | Finished Pharma Products & APIs Available